Hi class. I'm in New York for a meeting (related to this project, specifically), but here is my assignment 6. As per our discussion last week (and thank you everyone so much for all of the help) I've completely restarted my protocol. Since it was a lot to redo everything from the start, it's on the rough side, but I'll refine it over the next few weeks. Also pasted below is assignment 6 so that you don't have to scroll all the way down to read it. Thank you!
PROGRAM EVALUATION
Thinking about the protocol you are developing, identify the process and outcome indicators associated with the intervention/program and briefly describe an approach to measuring each.
Outcome variables and how they will be measured
- Adoption of tool (quantitative outcome) will be measured by calculating change in frequency of clinician accessing and completion of registry form over time (3, 6, and 12 months), which will be measured as follows:
- Frequency with which clinician accesses the tool: # of times clinician accesses tool/# of patient encounters by clinician
- Frequency of clinicians’ completion of registry form: # of times clinician completes registry form/# of patient encounters by clinician
The numerator in each equation will be accessed via the registry database, and the denominator in each equation will be accessed via the web-based health records at each site.
- Barriers/facilitators to implementation of tool (qualitative outcome): Participants at the three practice sites will be given the opportunity to participate in two focus group interviews designed to understand barriers/facilitators to adoption of registry tools.
Define one or more “intermediate” outcome measures [reflecting changes in environment, organizational culture, systems of care, patient or public behavior, and/or clinician behaviors] that can inform you about the mechanism by which your intervention achieves its downstream effect on health and inform you about the acceptability of your intervention.
Practices engaging in quality improvement processes as a result of feedback from data collected through the registry.
Identify a mixed methods study design and briefly describe the quantitative and qualitative data you will collect for program/intervention evaluation.
Study design: This will be a multi-site, mixed methods observational pilot study in a prospective cohort design.
Timing:Clinicians participating in registry use will be followed for 12 months. The study will begin when the registry has been integrated into the three home-centered practice sites involved in Stage 2 implementation. The study will end when the last participating clinician has been followed for 12 months.
Study participants: All participants will be clinicians (physicians, nurse practitioners, physician assistants) atsix home-centered primary care practices that have already been recruited to pilot the implementation of the quality measures and data registry. These sites reflect a diversity of practice types (rural/urban, academic/community-based, etc.) and are highly motivated to test the measures.
Outcome variables and how they will be measured : See above